Fortress Biotech, Inc. - Common Stock (NQ:FBIO)

1.860 -0.130 (-6.53%)

Delayed Quote Updated: 12:50 PM EST, Nov 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fortress Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >

36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022

January 28, 2022

RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public...

From MicroCap Rodeo

Via AccessWire

FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder ↗

January 25, 2022

The FDA has issued a hold, pending Chemistry, Manufacturing & Controls (CMC) clearance, on Mustang Bio Inc's (NASDAQ: MBIO) Investigational New Drug (IND)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 15, 2021

Gainers Calliditas Therapeutics (NASDAQ:

Via Benzinga

3 Penny Stocks That Wall Street Wants You To Buy Now ↗

April 21, 2021

Penny stocks are very risky, which is why they have such low prices. Many of the companies in this risky part of the market will go bankrupt. ...

Via Benzinga

Topics Bankruptcy

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 15, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) s...

Via Benzinga

Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)

November 12, 2021

NEW YORK, NY / ACCESSWIRE / November 12, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ:ATXI). About Avenue...

From Aegis Capital Corp.

Via AccessWire

Topics Retirement

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 14, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. The company's market cap stands at $683.4...

Via Benzinga

18 Stocks Moving in Thursday's Pre-Market Session ↗

October 14, 2021

Gainers TSR, Inc. (NASDAQ: TSRI) rose 40.2% to $12.89 in pre-market trading after the company reported record revenue for its first quarter. Cemtrex, Inc. (NASDAQ: CETX) rose 34....

Via Benzinga

The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts ↗

October 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Catalyst Biosciences Announces Resignation Of CFO Catalyst Biosciences, Inc...

Via Benzinga

Fortress-Backed Cyprium's Formulated Copper Histidinate Shows Efficacy In Rare Pediatric Disease ↗

October 08, 2021

Fortress Biotech Inc's (NASDAQ: FBIO) partner company, Cyprium Therapeutics Inc announced results from an efficacy and safety analysis of data ...

Via Benzinga

33 Stocks Moving In Wednesday's Mid-Day Session ↗

September 29, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares climbed 37% to $7.18. NuCana plc (NASDAQ: NCNA) jumped 31.4% to $3.1150. The FDA granted Fast Track designation to NuCana’s...

Via Benzinga

52 Biggest Movers From Yesterday ↗

September 30, 2021

Gainers Paltalk, Inc. (NASDAQ: PALT) shares jumped 60.1% to close at $8.39 on Wednesday. Smart Share Global Limited (NASDAQ: EM) jumped 36.2% to close at $3.91. Smart Share...

Via Benzinga

AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M ↗

September 29, 2021

AstraZeneca Plc (NASDAQ: AZN) will take complete control of Caelum Biosciences in a deal worth up to $500 million, sharpening its focus on rare-disease...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 29, 2021

Gainers Geovax Labs (NASDAQ:GOVX) shares increased by 23.44% to $5.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $32.6...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 18, 2021

Gainers Protagenic Therapeutics (NASDAQ:PTIX...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 17, 2021

Gainers Midatech Pharma (NASDAQ:MTP) share...

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 15, 2021

Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 14, 2021

Gainers RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 111.41% to $39.26 during Monday's regular session. As of 12:30 EST, this security is trading at a...

Via Benzinga

Why Fortress Biotech Stock Is Sinking Today ↗

June 14, 2021

The FDA refused to approve IV tramadol for the second time.

Via The Motley Fool

40 Stocks Moving In Monday's Mid-Day Session ↗

June 14, 2021

Gainers Enochian Biosciences, Inc. (NASDAQ: ENOB) shares jumped 127.2% to $10.02. The FDA has accepted Enochian BioSciences Inc's pre-IND (Investigational New Drug) request...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 14, 2021

Gainers Enochian BioSciences (NASDAQ:ENOB) stock increased by 147.84% to $10.93 during Monday's pre-market session. The company's market cap stands at $522.4...

Via Benzinga

Mustang Bio's CAR T Cell Therapy Achieves 93% ORR, 67% CR In Mid-Stage Leukemia Trial ↗

June 11, 2021

Mustang Bio Inc (NASDAQ: MBIO) has updated interim data from the ongoing Phase 1/2 trial evaluating MB-106 for high-risk B-cell non-Hodgkin lymphomas (B-NHL) and...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics ↗

June 03, 2021

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...

Via Benzinga

35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

May 27, 2021

RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be...

From MicroCap Rodeo

Via AccessWire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 14, 2021

Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 18.37% to $31.44 during Wednesday's regular session. As of 12:31 EST, Nurix Therapeutics's stock is...

Via Benzinga

Why Fortress Biotech Stock Is Sinking Today ↗

April 13, 2021

Investors were not thrilled with the company's latest regulatory update.

Via The Motley Fool

50 Biggest Movers From Yesterday ↗

April 14, 2021

Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 75 Points; vTv Therapeutics Shares Spike Higher ↗

April 13, 2021

Toward the end of trading Tuesday, the Dow traded down 0.22% to 33,669.76 while the NASDAQ rose 0.80% to 13,960.92. The S&P also rose, gaining 0.28% to 4,139.55. The U.S. has...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.